A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells
Amineh Ghaderi(Karolinska University Hospital), Håkan Mellstedt(Karolinska University Hospital), Thomas Olin(Kancera (Sweden)), Birgitta Sander(Karolinska University Hospital), Anders Österborg(Karolinska University Hospital), Johanna Aschan(Karolinska University Hospital), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Mohammad Ali Okhovat(Karolinska University Hospital), Johan Schultz(Kancera (Sweden)), Wen Zhong(Karolinska University Hospital), Ann Svensson(University West)
Cited by 19
Related Papers
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2010|587
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312